Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating vesatolimod for safety and efficacy in ART-treated HIV-1 infected controllers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Vesatolimod (vesatolimod)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1 Infection | Phase 1 | Status: COMPLETED | Results posted: 2021-04-21